DHR
Price
$187.98
Change
-$2.07 (-1.09%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
184.93B
One day until earnings call
QDEL
Price
$25.30
Change
-$0.15 (-0.59%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
3.14B
10 days until earnings call
Interact to see
Advertisement

DHR vs QDEL

Header iconDHR vs QDEL Comparison
Open Charts DHR vs QDELBanner chart's image
Danaher
Price$187.98
Change-$2.07 (-1.09%)
Volume$33.9K
Capitalization184.93B
QuidelOrtho
Price$25.30
Change-$0.15 (-0.59%)
Volume$48.46K
Capitalization3.14B
DHR vs QDEL Comparison Chart in %
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. QDEL commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and QDEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (DHR: $190.05 vs. QDEL: $25.45)
Brand notoriety: DHR and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 114% vs. QDEL: 110%
Market capitalization -- DHR: $184.93B vs. QDEL: $3.14B
DHR [@Medical Specialties] is valued at $184.93B. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, QDEL is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 4 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 5 bearish.
  • QDEL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DHR is a better buy in the short-term than QDEL.

Price Growth

DHR (@Medical Specialties) experienced а -7.22% price change this week, while QDEL (@Medical Specialties) price change was -16.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.54%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was -2.57%.

Reported Earning Dates

DHR is expected to report earnings on Jul 22, 2025.

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+0.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than QDEL($3.14B). DHR has higher P/E ratio than QDEL: DHR (43.86) vs QDEL (9.76). DHR YTD gains are higher at: -16.949 vs. QDEL (-42.873). DHR has higher annual earnings (EBITDA): 7.5B vs. QDEL (607M). DHR has more cash in the bank: 5.86B vs. QDEL (167M). QDEL has less debt than DHR: QDEL (2.61B) vs DHR (19.5B). DHR has higher revenues than QDEL: DHR (23.9B) vs QDEL (3B).
DHRQDELDHR / QDEL
Capitalization185B3.14B5,888%
EBITDA7.5B607M1,235%
Gain YTD-16.949-42.87340%
P/E Ratio43.869.76450%
Revenue23.9B3B797%
Total Cash5.86B167M3,511%
Total Debt19.5B2.61B746%
FUNDAMENTALS RATINGS
DHR vs QDEL: Fundamental Ratings
DHR
QDEL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
55
Fair valued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
7893
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
7315
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (23) in the Medical Specialties industry is in the same range as QDEL (55). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

DHR's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as QDEL (100). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

DHR's SMR Rating (78) in the Medical Specialties industry is in the same range as QDEL (93). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

DHR's Price Growth Rating (62) in the Medical Specialties industry is in the same range as QDEL (64). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for DHR (73). This means that QDEL’s stock grew somewhat faster than DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRQDEL
RSI
ODDS (%)
Bearish Trend 5 days ago
53%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
55%
Bullish Trend 13 days ago
66%
Declines
ODDS (%)
Bearish Trend 7 days ago
59%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
68%
Aroon
ODDS (%)
Bullish Trend 4 days ago
58%
Bearish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTAX202.830.55
+0.27%
Rydex Technology H
MIEIX39.22-0.02
-0.05%
MFS International Equity R6
FAOFX18.57-0.02
-0.11%
Fidelity Advisor Series Growth Opps
PECAX16.52-0.05
-0.30%
JPMorgan SMID Cap Equity A
QUASX62.87-0.40
-0.63%
AB Small Cap Growth A

DHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHR
1D Price
Change %
DHR100%
-2.43%
TMO - DHR
77%
Closely correlated
-2.41%
MTD - DHR
71%
Closely correlated
-0.90%
RVTY - DHR
70%
Closely correlated
-2.36%
BIO - DHR
69%
Closely correlated
-1.30%
WAT - DHR
68%
Closely correlated
-3.24%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with BIO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-4.61%
BIO - QDEL
52%
Loosely correlated
-1.30%
DHR - QDEL
51%
Loosely correlated
-2.43%
RVTY - QDEL
51%
Loosely correlated
-2.36%
ITGDF - QDEL
50%
Loosely correlated
N/A
XRAY - QDEL
50%
Loosely correlated
-0.63%
More